September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Aqueous humour cytokines in Fuchs uveitis syndrome patients with or without secondary glaucoma
Author Affiliations & Notes
  • Carsten Heinz
    Ophthalmology, St. Franziskus Hospital, Muenster, Germany
    Ophthalmology, University Duisburg-Essen, Essen, Germany
  • Maren Kasper
    Ophthalmology, St. Franziskus Hospital, Muenster, Germany
  • Ozan Tektas
    Anatomy, University Nuremberg-Erlangen, Erlangen, Germany
  • Dirk Bauer
    Ophthalmology, St. Franziskus Hospital, Muenster, Germany
  • Karoline Walscheid
    Ophthalmology, St. Franziskus Hospital, Muenster, Germany
  • Joerg Koch
    Ophthalmology, St. Franziskus Hospital, Muenster, Germany
  • Philipp Muether
    Ophthalmology, University Koeln, Koeln, Germany
  • Arnd Heiligenhaus
    Ophthalmology, St. Franziskus Hospital, Muenster, Germany
    Ophthalmology, University Duisburg-Essen, Essen, Germany
  • Footnotes
    Commercial Relationships   Carsten Heinz, None; Maren Kasper, None; Ozan Tektas, None; Dirk Bauer, None; Karoline Walscheid, None; Joerg Koch, None; Philipp Muether, None; Arnd Heiligenhaus, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3304. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Carsten Heinz, Maren Kasper, Ozan Tektas, Dirk Bauer, Karoline Walscheid, Joerg Koch, Philipp Muether, Arnd Heiligenhaus; Aqueous humour cytokines in Fuchs uveitis syndrome patients with or without secondary glaucoma. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3304.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Secondary glaucoma in patients with Fuchs uveitis syndrome (FUS) is a common sight-threating complication. Aim of this observational study was to analyse changes in anterior chamber cytokine concentrations in FUS patients by multiplex bead-assay analysis.

Methods : Overall, 24 cataract control eyes (C), 11 eyes with FUS without glaucoma (FUSwoG), and 8 FUS eyes with glaucoma (FUSwG) were included. Samples were collected either during cataract surgery (C and FUSwoG), or during trabeculectomy (FUSwG). None of the eyes had active inflammation, as defined by AC cells during 3 months prior to surgery. Concentrations of interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), matrix metalloproteinases -1,-2,-3,-9 (MMP-1,-2,-3,-9), Serum Amyloid A (SAA), Transforming Growth Factor beta-1,-2,-3 (TGFβ-1,-2,-3), and Tumor Necrosis factor alpha (TNF-α) were measured by Multiplex Bead Assay analysis (Luminex® Performance Assay TGF-β Multiplex Kit R&D Systems Abingdon UK; Procarta® Immunoassay Affymetrix, Santa Clara US).

Results : At sample collection, control patients were with 75.5 ± 9.1 years older than patients with FUSwoG (33.7 ± 10.6 years), or FUSwG (43.1 ± 6.5 years (ANOVA p<0,001). No significant difference with regard to preoperative topical steroid therapy, or non-invasive laser flare-photometric values could be detected (9.2 ± 6.6 photons/ms vs 29.2 ± 50.6, p=0.4). No differences between all three groups could be detected for the SAA, MMP-1, TGF-β2, -β3, and TNF- α concentrations (p>0.0045 after Bonferroni correction for multiple testing). Il-8 was highest in FUSwG, and also significantly higher in FUSwoG as compared to C (p<0.001), while MMP-2, -3, and TGF-β1 were only significantly higher in eyes with FUSwG than in FUSwoG and C (p for all at least <0.0045). MMP-9 and MCP-1 had the highest concentrations in eyes from FUSwoG compared to the two other groups (p<0.001) and MCP-1 was additionally elevated in FUSwG compared to C.

Conclusions : Concentrations of anterior chamber cytokine vary significantly between eyes with or without secondary glaucoma in FUS. MMP-2 and -3 and TGF-β1 might play a role in pathogenesis of secondary glaucoma in FUS patients, while MMP-9 and MCP-1 seem to prevent glaucoma in eyes with Fuchs uveitis syndrome.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×